Insulin Degludec + Insulin Aspart Premixed

Introduction

Insulin Degludec + Insulin Aspart Premixed is a combination insulin product designed for the management of diabetes mellitus. It includes Insulin Degludec, a long-acting insulin, and Insulin Aspart, a rapid-acting insulin. This combination provides both basal and bolus insulin coverage, aiming to maintain better glycemic control throughout the day.

Uses

This premixed insulin is used to:

• Manage blood glucose levels in adults and children with Type 1 or Type 2 diabetes mellitus.
• Provide a combination of long-acting and rapid-acting insulin to cover both basal and prandial (meal-related) insulin needs.

Mechanism of Action

Insulin Degludec is a long-acting insulin that provides a steady level of insulin throughout the day and night by forming soluble multi-hexamers that slowly dissociate into monomers, providing a prolonged duration of action. Insulin Aspart is a rapid-acting insulin that quickly lowers blood glucose levels by facilitating the uptake of glucose into cells after meals. The combination ensures both steady glucose control and rapid postprandial glucose management.

How Long Does It Take to Work?

Insulin Aspart starts to work within 15 minutes of injection, reaching its peak effect in about 1 to 3 hours. Insulin Degludec starts to lower blood glucose levels within 1 to 2 hours, with its effects lasting up to 42 hours. The combination provides immediate coverage with Insulin Aspart and extended coverage with Insulin Degludec.

Absorption

Insulin Aspart is quickly absorbed from the subcutaneous tissue into the bloodstream, providing rapid onset of action. Insulin Degludec is absorbed more slowly due to its formation of long-acting hexamers, resulting in a gradual and prolonged release of insulin into the bloodstream.

Route of Elimination

Insulin Degludec and Insulin Aspart are both primarily metabolized in the liver and kidneys. They are excreted through the urine, with Insulin Degludec having a more prolonged metabolism due to its extended action profile.

Dosage

The dosage of Insulin Degludec + Insulin Aspart Premixed varies based on individual patient needs and glucose control goals. Common dosing schedules include:

• Typically administered twice daily before meals (morning and evening).
• The dose is individualized based on blood glucose levels, dietary intake, and physical activity.
• Starting doses often range from 10 to 40 units per day, adjusted according to patient response and blood glucose monitoring.

Administration

Insulin Degludec + Insulin Aspart Premixed is administered via subcutaneous injection. Common injection sites include the abdomen, thighs, or upper arms. It is important to rotate injection sites to avoid lipodystrophy. The medication should be injected 15 to 30 minutes before meals.

Side Effects

Common side effects include:

• Hypoglycemia (low blood sugar).
• Weight gain.
• Injection site reactions (pain, redness, swelling).
• Allergic reactions.

Toxicity

Toxicity primarily manifests as severe hypoglycemia. In cases of overdose or improper use, symptoms such as dizziness, shakiness, headache, and confusion may occur. Immediate treatment with glucose or glucagon is necessary to counteract hypoglycemia. Seek medical attention if symptoms persist.

Precautions

Precautions include:

• Regular monitoring of blood glucose levels to adjust dosing as needed.
• Monitoring for signs of hypoglycemia and hyperglycemia.
• Adjusting doses based on changes in diet, exercise, or stress levels.
• Informing healthcare providers of any changes in medical condition or concurrent medications.

Interaction

Potential interactions with other medications include:

• Drugs that affect blood glucose levels, such as corticosteroids or beta-blockers.
• Medications that alter insulin metabolism or excretion.

Disease Interaction

Use with caution in patients with:

• Renal or hepatic impairment, which can affect insulin metabolism and clearance.
• Heart disease or other chronic conditions that might influence blood glucose control.

Drug Interaction

Drug interactions may include:

• Other antidiabetic agents that can alter blood glucose levels.
• Medications that may enhance or diminish the effects of insulin.

Food Interactions

Food interactions are minimal but it is important to coordinate insulin administration with meal times to optimize blood glucose control. Consistent carbohydrate intake and meal timing can help prevent hypoglycemia and hyperglycemia.

Pregnancy Use

Insulin Degludec + Insulin Aspart Premixed is generally considered safe during pregnancy. However, glycemic control is crucial, and adjustments may be necessary. Consultation with a healthcare provider is essential to balance insulin needs and ensure the health of both the mother and the fetus.

Lactation Use

Insulin Degludec + Insulin Aspart is excreted in breast milk in small amounts. It is generally considered safe for use during lactation. Regular monitoring of blood glucose levels is recommended, and adjustments may be necessary to maintain optimal glucose control while breastfeeding.

Acute Overdose

Acute overdose can result in severe hypoglycemia. Treatment involves immediate glucose administration either orally or intravenously, depending on the severity of the hypoglycemia. Seek emergency medical attention if severe symptoms occur.

Contraindication

Contraindications include:

• Hypoglycemia or hypersensitivity to insulin or any of the components in the formulation.
• Conditions where insulin therapy is not indicated, such as in patients with insulinoma or during certain acute illnesses without proper management.

Use Direction

Follow the prescribed dosage and administration instructions provided by the healthcare provider. Regularly monitor blood glucose levels and adjust doses as needed based on blood glucose readings and lifestyle changes.

Storage Conditions

Store at 2°C to 8°C (36°F to 46°F) in the refrigerator. Do not freeze. Once in use, the insulin can be stored at room temperature (below 30°C or 86°F) for up to 28 days. Keep out of reach of children and avoid exposing the insulin to excessive heat or light.

Volume of Distribution

The volume of distribution is not explicitly defined for the premixed combination as it varies between Insulin Degludec and Insulin Aspart. Generally, insulin is distributed throughout the extracellular fluid space.

Half Life

Insulin Aspart has a half-life of approximately 1 to 2 hours, while Insulin Degludec has a prolonged half-life of up to 25 hours. The combination provides both rapid and extended glycemic control.

Clearance

Both Insulin Degludec and Insulin Aspart are cleared from the body primarily through the kidneys and liver. The clearance rate can be affected by renal and hepatic function, which may necessitate dose adjustments in patients with impaired function.